SARS-CoV-2, COVID-19 Rates Decreased After One Vaccine Dose
Study among health care workers shows reductions in SARS-CoV-2 infection rates one to 14, 15 to 28 days after first dose of the BNT162b2 COVID-19 vaccine
Persistent Symptoms Reported for About 30 Percent With COVID-19
At least one persistent symptom reported by 32.7 percent of outpatients with mild illness, 31.3 percent of patients hospitalized
Proinflammatory, Low-Quality Maternal Diet Linked to Adiposity
Odds of late childhood overweight and obesity increased with more proinflammatory diet in early pregnancy
COVID-19 Vaccine Efficacy Higher With Three-Month Interval Between Doses
For ChAdOx1 nCoV-19 Oxford vaccine, three-month interval results in higher efficacy than six-week interval
Prevalence Data Suggest Increasing Trend of Psoriasis With Age
Worldwide studies suggest stable or slightly decreasing trend in incidence of psoriasis and increasing trend in prevalence
All British Adults Should Have First COVID-19 Shot by July 31: Government
Announcement made as government prepares a 'cautious' reopening plan
Among Blacks, Late-Stage HIV Diagnosis Varies by Rurality
Across rural, urban, metropolitan areas, linkage to care within one month of diagnosis was similar but below targets
Age-Adjusted Suicide Rates Decreased From 2018 to 2019 in U.S.
2019 rates significantly lower in women aged 25 to 44 years and in boys and men aged 10 to 14, 45 to 64, and 65 to 74 years
Physician’s Briefing Weekly Coronavirus Roundup
Pfizer to Begin Clinical Trial of COVID-19 Vaccine in Pregnant Women
Pfizer also planning to start trials of the vaccine in younger children, teens, people with weakened immune systems
